Masthead small

Medication Abortion

There are currently several high-profile cases moving through the courts causing confusion about access to mifepristone. In one such case, Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, anti-abortion advocates are challenging the FDA's authority in the approval of mifepristone. SMFM has weighed in at every stage, affirming the safety and efficacy of mifepristone and denouncing the case as baseless. We will continue to monitor these cases closely and provide updates below.

SMFM members with questions regarding the status of mifepristone’s approval or any state-imposed restrictions on its use should consult with counsel or contact the Abortion Defense Network, a coalition of attorneys and legal organizations that can provide legal advice, resources, and assistance in evaluating the impact of this ruling and other legal issues for providers in a post-Roe landscape.

SMFM’s support for reproductive rights and freedom is unwavering. Learn more about our efforts to protect and expand access to abortion care, review clinical resources, and see how you can get involved at Questions? Contact RHProject@smfm.

Find an MFM Specialist